Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years
Conditions
HPV Infections · Cervical Cancer Stage IIa · Vaginal Cancer · Genital Wart · CIN1 · CIN2 · CIN3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Center for Disease Control and Prevention, Mianyang, Sichuan, China
Study leads
Ting Huang
Study Director
Sichuan Provincial Center for Disease Control and Prevention